back to Australia directory
australia clinical guidance

Tinea (corporis/cruris/pedis) and dermatophyte skin infections

A detailed Australian summary of tinea (corporis/cruris/pedis) and dermatophyte skin infections, with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Confirm an annular scaly edge or interdigital pattern and examine nails, scalp and other reservoirs; sample atypical or treatment-resistant disease. Use topical antifungal treatment for limited skin disease and continue for the source-recommended duration beyond visible clearing. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:National Healthy Skin Guideline

The Bottom Line

  • Confirm an annular scaly edge or interdigital pattern and examine nails, scalp and other reservoirs; sample atypical or treatment-resistant disease.
  • Use topical antifungal treatment for limited skin disease and continue for the source-recommended duration beyond visible clearing.
  • Moccasin-type foot scale and nail infection can sustain recurrent groin or body disease and need reservoir management.
  • Avoid topical corticosteroid鈥揳ntifungal combinations that mask morphology and create tinea incognito unless a specialist indication exists.
sources for this section:National Healthy Skin Guideline

Practical clinical workflow

1

Topic-specific assessment action

Confirm an annular scaly edge or interdigital pattern and examine nails, scalp and other reservoirs; sample atypical or treatment-resistant disease.
2

Topic-specific diagnostic action

Avoid topical corticosteroid鈥揳ntifungal combinations that mask morphology and create tinea incognito unless a specialist indication exists.
3

Topic-specific management action

Systemic therapy needs diagnostic confidence, interaction and liver-risk review, pregnancy consideration and current TGA product information.
4

Topic-specific follow-through

In remote Aboriginal communities, follow the National Healthy Skin Guideline and local environmental-health programme.
sources for this section:National Healthy Skin Guideline

Safety boundaries and escalation

  • Extensive disease, scalp or nail involvement, immunocompromise, secondary cellulitis or failure despite adherence warrants further investigation or referral.
  • A potassium-hydroxide preparation or fungal culture can prevent unnecessary systemic therapy when morphology is altered.
sources for this section:National Healthy Skin Guideline

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO鈥揜ACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:National Healthy Skin Guideline

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:National Healthy Skin Guideline

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Telethon Kids InstituteNational Healthy Skin Guideline: for the prevention, treatment and public health control of impetigo, scabies, crusted scabies and tinea2nd edition, 2023 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.